MarketBeat
08 Aug 2026, 23:04 UTC · 12w ago
Oscar Health Q2 Earnings Call Highlights
Impact · against what's priced in
Oscar Health's significant upward revision to full-year operating guidance and record H1 profitability act as a strong positive catalyst. While expected increases in membership churn present a headwind, the scale of earnings growth and MLR improvement outweighs these concerns.
- OSCR+0.70
No priced-in read yet
- In context
The company raised its 2026 earnings-from-operations forecast by $250 million to a range of $500 million to $700 million and reported $1 billion in H1 net income, demonstrating a rapid scale-up in profitability.
Read from the article alone
